Literature DB >> 20616594

Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography.

Shigeki Arii1, S Tanaka, Y Mitsunori, N Nakamura, A Kudo, N Noguchi, T Irie.   

Abstract

Here we described our strategies to attain a better prognosis for hepatocellular carcinoma (HCC) patients by surgery. Among a variety of attempts conducted to date, we focused on anatomical resection and intraoperative contrast-enhanced ultrasonography. There are still controversies with respect to the significance of anatomical resection. We analyzed the significance of this surgical procedure in 207 patients without macrovascular invasion. These patients underwent either anatomical resection or non-anatomical resection. We found that the patients with anatomical resection had higher recurrence-free survival rate than those with non-anatomical resection. Univariable analysis showed that liver damage, the serum level of alpha-fetoprotein, tumor number, surgical margin, and type of surgery (anatomical or non-anatomical resection) were significant predictive factors for intrahepatic recurrence. Multivariable analysis revealed that multiple tumors, alpha-fetoprotein, and non-anatomical resection were independent risk factors for recurrence. We conclude that anatomical resection is a recommendable surgical procedure in patients without macrovascular invasion. A recent innovation is the development of contrast-enhanced ultrasonography. Then we have applied this to liver surgery intraoperatively. We confirm that vascular images contribute to a precise diagnosis and the detection of small portal tumor thrombi, and that Kupffer images are useful to discover the minute tumors. In addition, by clarifying the relationship between tumors and the vascular architecture, real-time 3-dimensional images using Kupffer imaging are a promising guide during the surgical procedures, although further development is needed. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20616594     DOI: 10.1159/000315240

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  28 in total

1.  Outcomes of central bisectionectomy for hepatocellular carcinoma.

Authors:  Thomas K Gallagher; Albert C Y Chan; Ronnie T P Poon; Tan To Cheung; Kenneth S H Chok; See Ching Chan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2012-11-21       Impact factor: 3.647

Review 2.  Liver resection and transplantation in hepatocellular carcinoma.

Authors:  J Belghiti; D Fuks
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

3.  Management of hepatocellular carcinoma: Enlightening the gray zones.

Authors:  Andrea Mancuso
Journal:  World J Hepatol       Date:  2013-06-27

4.  Multiple Tumors Located in the Same Section Are Associated with Better Outcomes After Hepatic Resection for HCC Patients Meeting the Milan Criteria.

Authors:  Tao Lv; Li Jiang; Lunan Yan; Jiayin Yang; Bo Li; Tianfu Wen; Yong Zeng; Wentao Wang; Mingqing Xu
Journal:  J Gastrointest Surg       Date:  2015-09-22       Impact factor: 3.452

5.  Image classification of liver cancer surrounding right hepatic pedicle and its guide to precise liver resection.

Authors:  Xiao-Peng Chen; Wei-Dong Zhang; Dong Wang; Wei Cui; Yuan-Lin Yu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 6.  HCC: current surgical treatment concepts.

Authors:  F Cauchy; D Fuks; J Belghiti
Journal:  Langenbecks Arch Surg       Date:  2012-06       Impact factor: 3.445

Review 7.  New insights in hepatocellular carcinoma: from bench to bedside.

Authors:  Samuele De Minicis; Marco Marzioni; Antonio Benedetti; Gianluca Svegliati-Baroni
Journal:  Ann Transl Med       Date:  2013-07

Review 8.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

9.  Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.

Authors:  Jia-Zhou Ye; Yong-Quan Zhang; Hai-Hong Ye; Tao Bai; Liang Ma; Bang-De Xiang; Le-Qun Li
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Synchronous primary breast cancer and hepatocellular carcinoma in a male patient: a case report.

Authors:  Fei Tian; Xiuzheng Cui; Lin Li; Haizhen Lu; Weiqi Rong; Chao Bi; Jianxiong Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.